Stockscreener 앱 받기
34.49
2.10%
0.71
시장 영업 전:
34.49
Arrowhead Pharmaceuticals Inc (ARWR) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-12-30 | 2024-09-30 | 2024-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
94.88%
27.77
|
542.71 | 2.50 | - | - |
| Operating Expenses |
19.70%
193.32
|
161.51 | 163.91 | 162.20 | 176.14 |
| Benefits Costs and Expenses |
19.51%
206.86
|
173.09 | 177.62 | 172.80 | 173.98 |
| Costs And Expenses |
19.51%
206.86
|
173.09 | 177.62 | 172.80 | 173.98 |
| Depreciation and Amortization |
6.223
|
- | - | 5.025 | 4.782 |
| Operating Income/Loss |
143.43%
-165.55
|
381.20 | -161.41 | -162.20 | -176.14 |
| Nonoperating Income/Loss |
16.86%
-13.54
|
-11.59 | -13.70 | -10.60 | 2.164 |
| Income/Loss From Continuing Operations Before Tax |
148.45%
-179.09
|
369.62 | -175.22 | -172.80 | -173.98 |
| Income Tax Expense/Benefit |
124.93%
-0.437
|
1.753 | 0.103 | 0.546 | - |
| Income/Loss From Continuing Operations After Tax |
148.56%
-178.65
|
367.86 | -175.22 | -173.34 | -173.98 |
Net Income/Loss
|
148.56%
-178.65
|
367.86 | -175.22 | -173.34 | -173.98 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
32.11%
-3.411
|
-2.582 | - | -2.808 | -3.184 |
| Basic Average Shares |
4.26%
139.04
|
133.36 | -4.304 | 1.524 | 124.20 |
| Diluted Average Shares |
3.39%
139.04
|
134.48 | -4.219 | 1.524 | 124.20 |
| Basic Earnings Per Share |
145.32%
-1.26
|
2.78 | -1.25 | -1.37 | -1.38 |
| Diluted Earnings Per Share |
145.82%
-1.26
|
2.75 | -1.23 | -1.37 | -1.38 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.36%
1.10%
자본화:
|
볼륨(24시간):